Skip to main content
logo
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
15.26
-0.22 (-1.42%)
Oct 12, 2026, 1:32 PM EDT - Market open

Ultragenyx Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,5002,2153,8823,9263,2485,732
Market Cap Growth
-49.57%-42.94%-1.13%20.88%-43.33%-37.41%
Enterprise Value
2,2662,6383,9914,3553,1495,183
Last Close Price
15.4823.0042.0747.8246.3384.09

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.093.296.939.058.9416.31
PB Ratio
--30.3414.8214.269.216.21
P/TBV Ratio
--117.6460.6521.957.67

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.163.927.1310.038.6714.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-4.23-17.153.473.392.570.43
Net Debt / Equity Ratio
-2.70-7.050.630.570.03-0.66
Net Debt / EBITDA Ratio
-1.65-1.03-0.33-0.29-0.021.64
Net Debt / FCF Ratio
-1.57-1.09-0.39-0.30-0.021.47
Asset Turnover
0.560.440.370.290.240.21
Inventory Turnover
16.4217.7119.6322.8234.1535.05
Quick Ratio
1.412.192.142.323.044.33
Current Ratio
1.732.482.382.613.384.72
Return on Equity (ROE)
--608.47%-211.75%-193.34%-110.96%-43.72%
Return on Assets (ROA)
-24.22%-22.03%-22.38%-23.42%-26.44%-14.54%
Return on Capital Employed (ROCE)
-54.50%-46.60%-46.20%-47.00%-50.50%-28.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-39.04%-25.96%-14.66%-15.46%-21.78%-7.92%
FCF Yield
-32.58%-21.31%-10.85%-13.22%-15.29%-7.18%
Buyback Yield / Dilution
-4.21%-8.95%-23.13%-5.13%-3.13%-11.42%
SEC Filings: 10-K · 10-Q